Cargando…
Descriptive Aspects of Injection Drug Users in Iran’s National Harm Reduction Program by Methadone Maintenance Treatment
BACKGROUND: The Ministry of Health, Treatment and Medical Education of Iran has recently announced an estimated figure of 200,000 injecting drug users (IDUs). The aim of this study was to pilot a national program using demographics, types of drug abuse and prevalence of blood-borne infections among...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Tehran University of Medical Sciences
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3744255/ https://www.ncbi.nlm.nih.gov/pubmed/23967426 |
_version_ | 1782280569115115520 |
---|---|
author | ESKANDARIEH, Sharareh NIKFARJAM, Ali TARJOMAN, Termeh NASEHI, Abassali JAFARI, Firoozeh SABERI-ZAFARGHANDI, Mohammad-Bagher |
author_facet | ESKANDARIEH, Sharareh NIKFARJAM, Ali TARJOMAN, Termeh NASEHI, Abassali JAFARI, Firoozeh SABERI-ZAFARGHANDI, Mohammad-Bagher |
author_sort | ESKANDARIEH, Sharareh |
collection | PubMed |
description | BACKGROUND: The Ministry of Health, Treatment and Medical Education of Iran has recently announced an estimated figure of 200,000 injecting drug users (IDUs). The aim of this study was to pilot a national program using demographics, types of drug abuse and prevalence of blood-borne infections among IDUs. METHODS: In order to elicit data on demographics, types of drug abuse and prevalence of blood-borne infections among IDUs, a questionnaire was designed in the Bureau of Mental-Social Health and Addiction in collaboration with Iran’s Drug Control Headquarters of the Police Department. Therapeutical alliance of addiction in Shafagh Center was based on Methadone Maintenance Therapy (MMT). RESULTS: Among 402 reported IDUs most of them were male, single and in age range of 20 to 39 years old with 72.7% history of imprisonment. Most of them had elementary and high school education and a history of addiction treatment. The majority were current users of opioid, heroin and crack. The prevalence of blood-borne infections was 65.9% and 18.8% for HCV and HIV/AIDS infections, respectively. CONCLUSION: Prevention programs about harm reduction, treatment and counseling should include young IDUs as a core focus of their intervention structure. |
format | Online Article Text |
id | pubmed-3744255 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2013 |
publisher | Tehran University of Medical Sciences |
record_format | MEDLINE/PubMed |
spelling | pubmed-37442552013-08-21 Descriptive Aspects of Injection Drug Users in Iran’s National Harm Reduction Program by Methadone Maintenance Treatment ESKANDARIEH, Sharareh NIKFARJAM, Ali TARJOMAN, Termeh NASEHI, Abassali JAFARI, Firoozeh SABERI-ZAFARGHANDI, Mohammad-Bagher Iran J Public Health Original Article BACKGROUND: The Ministry of Health, Treatment and Medical Education of Iran has recently announced an estimated figure of 200,000 injecting drug users (IDUs). The aim of this study was to pilot a national program using demographics, types of drug abuse and prevalence of blood-borne infections among IDUs. METHODS: In order to elicit data on demographics, types of drug abuse and prevalence of blood-borne infections among IDUs, a questionnaire was designed in the Bureau of Mental-Social Health and Addiction in collaboration with Iran’s Drug Control Headquarters of the Police Department. Therapeutical alliance of addiction in Shafagh Center was based on Methadone Maintenance Therapy (MMT). RESULTS: Among 402 reported IDUs most of them were male, single and in age range of 20 to 39 years old with 72.7% history of imprisonment. Most of them had elementary and high school education and a history of addiction treatment. The majority were current users of opioid, heroin and crack. The prevalence of blood-borne infections was 65.9% and 18.8% for HCV and HIV/AIDS infections, respectively. CONCLUSION: Prevention programs about harm reduction, treatment and counseling should include young IDUs as a core focus of their intervention structure. Tehran University of Medical Sciences 2013-06-01 /pmc/articles/PMC3744255/ /pubmed/23967426 Text en Copyright © Iranian Public Health Association & Tehran University of Medical Sciences http://creativecommons.org/licenses/by-nc/3.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution NonCommercial 3.0 License (CC BY-NC 3.0), which allows users to read, copy, distribute and make derivative works for non-commercial purposes from the material, as long as the author of the original work is cited properly. |
spellingShingle | Original Article ESKANDARIEH, Sharareh NIKFARJAM, Ali TARJOMAN, Termeh NASEHI, Abassali JAFARI, Firoozeh SABERI-ZAFARGHANDI, Mohammad-Bagher Descriptive Aspects of Injection Drug Users in Iran’s National Harm Reduction Program by Methadone Maintenance Treatment |
title | Descriptive Aspects of Injection Drug Users in Iran’s National Harm Reduction Program by Methadone Maintenance Treatment |
title_full | Descriptive Aspects of Injection Drug Users in Iran’s National Harm Reduction Program by Methadone Maintenance Treatment |
title_fullStr | Descriptive Aspects of Injection Drug Users in Iran’s National Harm Reduction Program by Methadone Maintenance Treatment |
title_full_unstemmed | Descriptive Aspects of Injection Drug Users in Iran’s National Harm Reduction Program by Methadone Maintenance Treatment |
title_short | Descriptive Aspects of Injection Drug Users in Iran’s National Harm Reduction Program by Methadone Maintenance Treatment |
title_sort | descriptive aspects of injection drug users in iran’s national harm reduction program by methadone maintenance treatment |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3744255/ https://www.ncbi.nlm.nih.gov/pubmed/23967426 |
work_keys_str_mv | AT eskandariehsharareh descriptiveaspectsofinjectiondrugusersiniransnationalharmreductionprogrambymethadonemaintenancetreatment AT nikfarjamali descriptiveaspectsofinjectiondrugusersiniransnationalharmreductionprogrambymethadonemaintenancetreatment AT tarjomantermeh descriptiveaspectsofinjectiondrugusersiniransnationalharmreductionprogrambymethadonemaintenancetreatment AT nasehiabassali descriptiveaspectsofinjectiondrugusersiniransnationalharmreductionprogrambymethadonemaintenancetreatment AT jafarifiroozeh descriptiveaspectsofinjectiondrugusersiniransnationalharmreductionprogrambymethadonemaintenancetreatment AT saberizafarghandimohammadbagher descriptiveaspectsofinjectiondrugusersiniransnationalharmreductionprogrambymethadonemaintenancetreatment |